CDMO News
Anthem Biosciences Files for $397 Million IPO
Anthem Biosciences, an India-based contract development and manufacturing organization (CDMO), has filed for a public offering valued at approximately 33.95 billion rupees ($397 million). The move, announced at the end of 2024, aims to support the company’s ongoing expansion in
9 January 2025